Cargando…
A Case of Metastatic Adamantinoma That Responded Well to Sunitinib
Adamantinoma is a rare low-grade malignant bone tumor of epithelial origin. Metastatic adamantinoma has been reported to be resistant to chemotherapy. We report a case of metastatic adamantinoma to the lung, 10 years after the initial diagnosis of tibial mass. The patient received radiation therapy...
Autores principales: | Liman, Andrew D., Liman, Agnes K., Shields, Jenna, Englert, Becky, Shah, Rashmikant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005543/ https://www.ncbi.nlm.nih.gov/pubmed/27630780 http://dx.doi.org/10.1155/2016/5982313 |
Ejemplares similares
-
A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma
por: Liman, Andrew D., et al.
Publicado: (2018) -
A Rare Case of Systemic Mastocytosis With Associated Clonal Hematological Non-Mast Cell Lineage Disease That Transformed to Acute Leukemia With IDH2 Mutation
por: Liman, Andrew D., et al.
Publicado: (2020) -
Metastatic or metachronous adamantinoma: An Enigma
por: Ramaswamy, AS, et al.
Publicado: (2012) -
A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
por: Kuang, Chaoyuan, et al.
Publicado: (2020) -
Adamantinoma of the Tibia: A Case Report
por: Anoumou, Michel N., et al.
Publicado: (2014)